Beyond T2DM, the Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes trial is assessing whether GLP-1 RAs can meaningfully reduce MACE, HF hospitalizations, and other cardiovascular endpoints in patients with type 1 diabetes, a population generally underrepresented in cardiovascular prevention studies [66]
Protein intake becomes especially important on GLP-1 therapy because significant weight loss can include lean muscle mass if protein intake is inadequate
The stronger evidence for dementia prevention still centers on the basics that are easy to underestimate: blood pressure, lipids, glucose regulation, physical activity, sleep, hearing, vision, nutrition, social connection, and inflammation control
Comirnaty, mNexspike and Spikevax specifically target the LP.8.1 sublineage
Gastroenterology (2015) 149:38997.e10